HOME >> BIOLOGY >> NEWS
Mount Sinai receives NIH funding for stem cell research

The National Institute of General Medicine Sciences (NIGMS) announced today that Mount Sinai School of Medicine and two other centers will receive an estimated $9 million dollar grant over the next three years to further stem cell research. The grant supports a three year research initiative to establish a core facility to support and train scientists and to define the growth conditions and molecular characteristics required for maintaining human embryonic stem cells in an undifferentiated state. Scientists at the centers also will work on specific pilot projects to advance fundamental knowledge of human embryonic stem cell properties and functions.

During the first year of funding, researchers at Mount Sinai School of Medicine will study the growth, differentiation and genetic alteration of human embryonic stem cells. The group will focus on developing methods to genetically modify stem cells and will study the molecular signals that cause them to differentiate into red blood cells.

"We expect the center to play an important role in establishing the infrastructure that will enable basic scientists to explore many fascinating questions about stem cell biology," said Marion M. Zatz, Ph.D., program director for the grant at the National Institute of General Medical Sciences. "This fundamental knowledge is critical for efforts to use human embryonic stem cells therapeutically."

Mount Sinai School of Medicine has been at the forefront of stem cell research. Recently, the School announced a major gift from Mr. Leon Black, the founder of the investment managing firms Apollo Advisors, L. P. and Lion Advisors, L. P., and co-founder of Apollo Real Estate Advisors, L. P., to establish the Black Family Stem Cell Institute. The Institute will foster interdisciplinary collaboration among faculty members from numerous departments who are already working in stem cell research.


'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
10-Aug-2005


Page: 1

Related biology news :

1. Climate change isolates Rocky Mountain butterflies
2. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
3. Bronfman gift to Mount Sinai catalyzes genomics-based medicine
4. NIH establishes Center of Excellence for influenza research at Mount Sinai
5. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
6. Sensational find: The mini-dinosaurs from the Harz Mountains
7. Brookhaven Lab and Mount Sinai form joint Center for Translational Biomedical Imaging
8. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
9. University of Kentucky author captures national attention with Lost Mountain
10. Infectious disease expert warns of spread of Rocky Mountain spotted fever
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mount Sinai receives NIH funding for stem cell research

(Date:5/20/2013)... antibiotic colistin are also commonly resistant to antimicrobial ... a study in mBio , the online ... Cross-resistance to colistin and host antimicrobials LL-37 and ... attack, could mean that patients with life-threatening multi-drug ... immune response. Colistin is a last-line drug for ...
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
(Date:5/21/2013)... Clear Lake, MN (PRWEB) May 21, 2013 ... all-in-one trade show display solution for sales and marketing teams ... GLM Displays describes the kit as “everything you’ll need ... The Fusion Fabric Display Kit comes with a number of ... an all-around trade booth 20 feet by 20 feet in ...
(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
(Date:5/20/2013)... , May 20, 2013 Today, at ... San Francisco , James McGough ... Psychiatry at the Semel Institute for Neuroscience and Human ... of Medicine at the University of California Los Angeles ... Child and Adolescent Psychopharmacology and ADHD at UCLA, presented ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
Cached News: